Based on the expression characteristics of TIM-3, which is expressed both on AML cells and exhausted T cells (52, 57), TIM-3 blockade may have dual effects: directly inhibiting AML cell proliferation and revising the exhausted T cell phenotype and restoring T cell function. Here, HAVCR2 is linked to acute myeloid leukemia.